nach oben

01.02.2016 | Cardiac Nuclear Imaging (A. Cuocolo, Section Editor)

Cardiac Innervation Imaging: Implications for Risk Stratification and Therapeutic Decision-Making

verfasst von: Albert Flotats, Ignasi Carrió

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Heart failure (HF) is associated with reduced cardiac sympathetic neuronal uptake of norepinephrine (NE), which can be assessed noninvasively using different radiotracers and planar or single-photon emission computed tomography (SPECT)/positron emission tomography (PET) imaging. Such sympathetic derangement in HF patients has shown to be an indicator of unfavorable prognosis. Therefore, cardiac sympathetic imaging might be useful as an indicator of the effectiveness of the medical therapy and consequently for risk stratification of patients with HF to more effectively guide specific therapies. This article reviews the current status on the subject and evaluates the literature published over recent years.

Jacobson AF, Narula J. Introduction to cardiac neuronal imaging: a clinical perspective. J Nucl Med. 2015;56:3S–6.CrossRefPubMed

Nakajima K, Nakata T. Cardiac ¹²³I-MIBG imaging for clinical decision making: 22-year experience in Japan. J Nucl Med. 2015;56:11S–9.CrossRefPubMed

Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212–21.CrossRefPubMed

Petretta M, Pellegrino T, Cuocolo A. Cardiac neuronal imaging with 123I-meta-iodobenzylguanidine in heart failure: implications of endpoint selection and quantitative analysis on clinical decisions. Eur J Nucl Med Mol Imaging. 2014;41:1663–5.CrossRefPubMed

Ketchum ES, Jacobson AF, Caldwell JH, Senior R, Cerqueira MD, Thomas GS, et al. Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol. 2012;19:1007–16.CrossRefPubMed

Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation. 2009;120:835–42.PubMedCentralCrossRefPubMed

7.••

Narula J, Gerson M, Thomas GS, Cerqueira MD, Jacobson AF. 123I-MIBG imaging for prediction of mortality and potentially fatal events in heart failure: the ADMIRE-HFX study. J Nucl Med. 2015;56:1011–8. Demonstration of ¹²³ I-mIBG late HMR as independent prognostic marker, additive to currently available risk stratification procedures.

Parker MW, Sood N, Ahlberg AW, Jacobson AF, Heller GV, et al. Relationship between quantitative cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine and hospitalization in patients with heart failure. Eur J Nucl Med Mol Imaging. 2014;41:1666–72.CrossRefPubMed

Clements IP, Kelkar AA, Garcia EV, Butler J, Chen J, Folks R, et al. Prognostic significance of ¹²³I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure. Eur Heart J Cardiovasc Imaging 2015. doi:10.1093/ehjci/jev295.

10.

Clements IP, Chen J, Folks R, Butler J, Jacobson AF. Quantitative iodine 123 meta-iodobenzylguanidine (123I mIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: development and validation of automated procedures in conjunction with technetium-99 m tetrofosmin myocardial perfusion SPECT. J Nucl Cardiol 2015. doi:10.1007/s12350-015-0097-4.

11.

Shah AM, Bourgoun M, Narula J, Jacobson AF, Solomon SD. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with Iodine-123 MIBG in heart failure. J Am Coll Cardiol Img. 2012;5:1139–46.CrossRef

12.

Sood N, Al Badarin F, Parker M, Pullatt R, Jacobson AF, Bateman TM, et al. Resting perfusion MPI-SPECT combined with cardiac ¹²³I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial. J Nucl Cardiol. 2013;20:813–20.CrossRefPubMed

13.

Al Badarin FJ, Wimmer AP, Kennedy KF, Jacobson AF, Bateman TM. The utility of ADMIRE-HF risk score in predicting serious arrhythmic events in heart failure patients: incremental prognostic benefit of cardiac ¹²³I-mIBG scintigraphy. J Nucl Cardiol. 2014;21:756–62.CrossRefPubMed

14.

Saba S, Aban I, Soman P. ¹²³I-mIBG scintigraphy: yet another risk stratifier for the heart failure toolbox! J Nucl Cardiol. 2014;21:909–12.CrossRefPubMed

15.

JCS Joint Working Group. Guidelines for clinical use of cardiac nuclear medicine (JCS 2010) – digest version –. Circ J. 2012;76:761–7.CrossRef

16.

Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of ¹²³I-MIBG-imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging. 2013;6:772–84.CrossRefPubMed

17.

Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y, et al. Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol. 2014;21:970–8.PubMedCentralCrossRefPubMed

18.

Nakajima K, Nakata T, Yamada T, Yamashina S, Momose M, Kasama S, et al. A prediction model for 5-year cardiac mortality in patients with chronic heart failure using 123I-metaiodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging. 2014;41:1673–82.PubMedCentralCrossRefPubMed

19.••

Nakajima K, Nakata T, Matsuo T, Jacobson AF. Creation of mortality risk charts using ¹²³I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: two- and five year risk models. Eur Heart J Cardiovasc Imaging 2015. doi:10.1093/ehjci/jev322. Creation of clinically useful mortality risk charts with three common clinical variables including age, NYHA class and LVEF, together with ¹²³ I-mIBG late HMR for prognostic stratification in heart failure patients.

20.

Fallavollita JA, Heavey BM, Luisi Jr AJ, Michalek SM, Baldwa S, Mashtare Jr TL, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63:141–9.PubMedCentralCrossRefPubMed

21.••

Verschure DO, Veltman CE, Manrique A, Somsen GA, Koutelou M, Katsikis A, et al. For what endpoint does myocardial ¹²³I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. Eur Heart J Cardiovasc Imaging. 2014;15:996–1003. A meta-analysis showing the intermediate to long-term prognostic value of ¹²³ I-mIBG late HMR.

22.

Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter defibrillator patients. J Am Coll Cardiol. 2010;55:2769–77.CrossRefPubMed

23.

Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parizek P, Agostini D, et al. 123 I-MIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging. 2008;1:131–40.CrossRefPubMed

24.

Wessler BS, Udelson JE. Neuronal dysfunction and medical therapy in heart failure: can an imaging biomarker help to “personalize” therapy? J Nucl Med. 2015;56:20S–4.CrossRefPubMed

Titel: Cardiac Innervation Imaging: Implications for Risk Stratification and Therapeutic Decision-Making
verfasst von: Albert Flotats
Ignasi Carrió
Publikationsdatum: 01.02.2016
Verlag: Springer US
Erschienen in: Current Cardiovascular Imaging Reports / Ausgabe 2/2016
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-015-9368-3

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Cardiac Innervation Imaging: Implications for Risk Stratification and Therapeutic Decision-Making

Abstract

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Kardiologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adipositas-Medikament auch gegen Schlafapnoe wirksam

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

Update Kardiologie